| MEDI | Sunday, 28 August 2005 | ||
9:00 AM-12:20 PM Washington DC Convention Center -- 146A, Oral | |||
General Oral Session | |||
| Organizer: | David Rotella | ||
| Presiding: | Jeff A. Zablocki | ||
| 9:00 AM | 6 | Multiple 5-HT approaches to novel anti-depressants Simon E Ward | |
| 9:20 AM | 7 | Synthesis and structure-activity relationship of tricyclic piperidinylidenes and tropanylidenes, a novel class of delta opioid agonists Bart L. De Corte, John R Carson, Andrea B Works, Christine M Razler, Mark E. McDonnell, James J. McNally, Li Liu, Philip M. Pitis, Laura Andraka, Christopher A Teleha, Jef C. Proost, Sui-Po Zhang, Ellen E. Codd, Raymond W. Colburn, Dennis J. Stone, Lory J. Molino, Christopher R. Van Besien, Christopher M. Flores, Scott L. Dax | |
| 9:40 AM | 8 | Synthesis of small molecules designed to complement disease-associated thyroid hormone receptor mutants A. Quamrul Hassan, John T. Koh | |
| 10:00 AM | 9 | CDK2/CyclinA inhibitors: Targeting the cyclinA recruitment site with small molecules derived from peptide leads Daniel P. Sutherlin, Georgette M. Castanedo, Kevin Clark, Shumei Wang, Vickie Tsui, Mengling Wong, John B. Nicholas, Dineli Wickramasinghe, James Marsters | |
| 10:20 AM | 10 | Novel VEGFR-2 kinase inhibitors for the treatment of cancer Stephen J. Boyer, Jennifer M. Burke, Catherine R. Brennan, Warren Brini, William Collibee, Julie A. Dixon, Jacques Dumas, Frederick Ehrgott, Holia Hatoum-Mokdad, Zhenqui Hong, Harold C. Kluender, Wendy Lee, Xin Ma, Raymond Reeves, Robert N. Sibley, Tiffany Turner, Wai Wong, Yanlin Zhang, Cheryl Brink, Christopher Carter, Yong Chang, Du-Shieng Chien, Christian Cortes, James Elting, Randall M. Jones, Mark McHugh, Adrienne Natrillo, Barbara Polony, Patrick Vincent, Dean Wilkie, Deborah Webb, Guochang Zhu | |
| 10:40 AM | 11 | Synthesis and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP: N1-Ureas and C2-phenols Robert M. Garbaccio, Edward S. Tasber, Mark E. Fraley, George D. Hartman, Robert B. Lobell, Carolyn A. Buser, Weikang Tao, Hans E. Huber, Nancy E. Kohl, Lawrence C. Kuo, Youwei Yan, Maricel Torrent, Thomayant Prueksaritanont, Donald Slaughter | |
| 11:00 AM | 12 | Polyaminohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors Sheeba Varghese, Anchalee Jiemjit, Steven D. Gore, Tiffany Baran, Robert A. Casero, Patrick M. Woster | |
| 11:20 AM | 13 | Supramolecular photonic therapeutic agents: pH Responsive anti-cancer drugs Donal F. O'Shea, Shane McDonnell, Michael Hall | |
| 11:40 AM | 14 | Design and synthesis of an array of selective androgen receptor modulators Ryan P. Trump, Philip Turnbull, Jean-Baptiste E. Blanc, Robert W. Wiethe, Eugene L. Stewart, Matilde Caivano, David Gray, William J. Hoekstra, Timothy M. Willson | |
| 12:00 PM | 15 | Novel potent allosteric inhibitors of HCV NS5B polymerase Christian Brochu, René Coulombe, J. R. Gillard, E. Jolicoeur, Peter Kohlbauer, Peter Kühn, Marc-André Poupart, Sylvain Lefebvre, Ginette McKercher, George Kukolj, P. L. Beaulieu | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 230th ACS National Meeting, in Washington, DC, Aug 28-Sept 1, 2005